Outcomes of screening mammography by frequency, breast density, and postmenopausal hormone therapy.
暂无分享,去创建一个
Rebecca A Hubbard | Weiwei Zhu | Karla Kerlikowske | Karen J Wernli | Diana L Miglioretti | D. Miglioretti | R. Hubbard | K. Kerlikowske | Weiwei Zhu | B. Geller | K. Wernli | Kim Dittus | Ellen S O'Meara | Dejana Braithwaite | D. Braithwaite | K. Dittus | E. O'Meara | Berta Geller
[1] S. Duffy,et al. Size, node status and grade of breast tumours: association with mammographic parenchymal patterns , 2000, European Radiology.
[2] R. Langer,et al. Influence of estrogen plus progestin on breast cancer and mammography in healthy postmenopausal women: the Women's Health Initiative Randomized Trial. , 2003, JAMA.
[3] D. Miglioretti,et al. Modelling the cumulative risk of a false-positive screening test , 2010, Statistical methods in medical research.
[4] Jessica W T Leung,et al. Performance benchmarks for diagnostic mammography. , 2005, Radiology.
[5] C. Lehman,et al. Comparative Effectiveness of Digital Versus Film-Screen Mammography in Community Practice in the United States , 2011, Annals of Internal Medicine.
[6] Andrew J Evans,et al. Influence of mammographic parenchymal pattern in screening-detected and interval invasive breast cancers on pathologic features, mammographic features, and patient survival. , 2007, AJR. American journal of roentgenology.
[7] Timothy J Wilt,et al. Screening for breast cancer: U.S. Preventive Services Task Force recommendation statement. , 2009, Annals of internal medicine.
[8] Marvin Zelen,et al. Effects of Mammography Screening Under Different Screening Schedules: Model Estimates of Potential Benefits and Harms , 2009 .
[9] K. Kerlikowske,et al. Variability and accuracy in mammographic interpretation using the American College of Radiology Breast Imaging Reporting and Data System. , 1998, Journal of the National Cancer Institute.
[10] Emily White,et al. Association between Mammographic Breast Density and Breast Cancer Tumor Characteristics , 2005, Cancer Epidemiology Biomarkers & Prevention.
[11] Beth A Reboussin,et al. Postmenopausal hormone therapy and change in mammographic density. , 2003, Journal of the National Cancer Institute.
[12] S. Tyldesley,et al. Comparison of 1- and 2-year screening intervals for women undergoing screening mammography , 2005, British Journal of Cancer.
[13] Bernard Rosner,et al. Mammographic breast density and subsequent risk of breast cancer in postmenopausal women according to tumor characteristics. , 2011, Journal of the National Cancer Institute.
[14] S. Rubin,et al. Efficacy of screening mammography. A meta-analysis. , 1995, JAMA.
[15] D. Miglioretti,et al. Biennial versus annual mammography and the risk of late-stage breast cancer. , 2004, Journal of the National Cancer Institute.
[16] Timothy J Wilt,et al. Screening for breast cancer: U.S. Preventive Services Task Force recommendation statement. , 2009, Annals of internal medicine.
[17] K. Kerlikowske,et al. Breast Cancer Surveillance Consortium: a national mammography screening and outcomes database. , 1997, AJR. American journal of roentgenology.
[18] D. Miglioretti,et al. Individual and Combined Effects of Age, Breast Density, and Hormone Replacement Therapy Use on the Accuracy of Screening Mammography , 2003, Annals of Internal Medicine.
[19] D. Kopans,et al. Cumulative Probability of False-Positive Recall or Biopsy Recommendation After 10 Years of Screening Mammography: A Cohort Study , 2012 .
[20] Mckenzie Shaun,et al. アジュバント化学療法は米国対がん合同委員会(American Joint Committee on Cancer)の病期分類による第II期結腸癌患者の生残率を改善する , 2011 .
[21] N. Boyd,et al. Mammographic Density as a Surrogate Marker for the Effects of Hormone Therapy on Risk of Breast Cancer , 2006, Cancer Epidemiology, Biomarkers and Prevention.
[22] Andrea J Cook,et al. Breast cancer risk by breast density, menopause, and postmenopausal hormone therapy use. , 2010, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[23] Karla Kerlikowske,et al. The mammogram that cried Wolfe. , 2007, The New England journal of medicine.
[24] H. Nelson,et al. Screening for Breast Cancer: An Update for the U.S. Preventive Services Task Force , 2009, Annals of Internal Medicine.
[25] V. Beral,et al. Hormone replacement therapy and false positive recall in the Million Women Study: patterns of use, hormonal constituents and consistency of effect , 2005, Breast Cancer Research.
[26] Mark A Helvie,et al. Invasive cancers detected after breast cancer screening yielded a negative result: relationship of mammographic density to tumor prognostic factors. , 2004, Radiology.
[27] C M Rutter,et al. Changes in breast density associated with initiation, discontinuation, and continuing use of hormone replacement therapy. , 2001, JAMA.
[28] Celine M Vachon,et al. Case-control study of increased mammographic breast density response to hormone replacement therapy. , 2002, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.
[29] Michael J. Carston,et al. Association of Mammographic Density with the Pathology of Subsequent Breast Cancer among Postmenopausal Women , 2008, Cancer Epidemiology Biomarkers & Prevention.
[30] K. Kerlikowske,et al. Detection of ductal carcinoma in situ in women undergoing screening mammography. , 2002, Journal of the National Cancer Institute.
[31] H. D. de Koning,et al. Tipping the Balance of Benefits and Harms to Favor Screening Mammography Starting at Age 40 Years , 2012, Annals of Internal Medicine.
[32] Karla Kerlikowske,et al. Using Clinical Factors and Mammographic Breast Density to Estimate Breast Cancer Risk: Development and Validation of a New Predictive Model , 2008, Annals of Internal Medicine.
[33] D. Miglioretti,et al. Prognostic characteristics of breast cancer among postmenopausal hormone users in a screened population. , 2003, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[34] H. Nelson,et al. Screening for Breast Cancer: Systematic Evidence Review Update for the U. S. Preventive Services Task Force , 2009 .
[35] D. Berry,et al. Breast Cancer Working Group of the Cancer Intervention and Surveillance Modeling Network. Effects of mammography screening under different screening schedules: Model estimates of potential benefits and harms (Annals of Internal Medicine (2009) 151, (738-747)) , 2010 .
[36] S. Cummings,et al. Personalizing Mammography by Breast Density and Other Risk Factors for Breast Cancer: Analysis of Health Benefits and Cost-Effectiveness , 2011, Annals of Internal Medicine.
[37] Rongwei Fu,et al. Risk Factors for Breast Cancer for Women Aged 40 to 49 Years , 2012, Annals of Internal Medicine.
[38] D. Miglioretti,et al. Longitudinal measurement of clinical mammographic breast density to improve estimation of breast cancer risk. , 2007, Journal of the National Cancer Institute.
[39] S. Ciatto,et al. Categorizing breast mammographic density: intra- and interobserver reproducibility of BI-RADS density categories. , 2005, Breast.
[40] Diana L Miglioretti,et al. Reproducibility of BI‐RADS Breast Density Measures Among Community Radiologists: A Prospective Cohort Study , 2012, The breast journal.